Navigation Links
Mental health treatment extends lives of older patients with diabetes and depression
Date:12/5/2007

PHILADELPHIA Researchers at the University of Pennsylvania School of Medicine report that older adults with diabetes and depression are half as likely to die over a 5-year period when they receive depression care management than depressed patients with diabetes who do not receive depression care management. The first known study to examine the relationship between diabetes and mortality in a depression intervention trial appears in the December issue of Diabetes Care.

Depression is common among people with diabetes and contributes to issues with medication and diet adherence, and also leads to an overall reduced quality of life, says lead author, Hillary R. Bogner, MD, MSCE, Assistant Professor, Department of Family Practice and Community Medicine at Penn.

The multi-site, practice-randomized controlled trial was conducted in 20 primary care practices in New York City, Philadelphia, and Pittsburgh. A total of 584 participants 60 94 years of age were identified through a depression screening, and of these participants, 123 reported a history of diabetes. The practices were randomly assigned to usual care, or a depression care management intervention, which involved a depression care manager who worked with the primary care provider to recommend treatment for depression and assist patients with treatment adherence.

At follow-up, 110 depressed patients had died. Depressed, older adults with diabetes who were in practices randomized to depression care management were less likely to have died at the end of the 5-year follow-up than were depressed, older adults with diabetes who received usual care. The authors note that they believe these findings support the integration of depression evaluation and treatment with diabetes management in primary care.


'/>"/>

Contact: Kate Olderman Tavella
kate.olderman@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1

Related medicine news :

1. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
7. How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
8. Experimental drug shows promise in advanced kidney cancer
9. Experimental Antidepressants Offer Faster Relief
10. Environmental stress probed in cardiovascular disease, diabetes
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...toid arthritis, could help newly diagnosed diabeti...HealthDay News) -- A drug commonly used to treat n... also shows some promise in helping patients newly...tuximab (Rituxan), helped patients keep producing ... had destroyed some of their pancreatic beta cells...
(Date:11/25/2009)...ns of trouble with the H1N1 vaccine, , ,...ng H1N1 swine flu pandemic may be driving a recent...nts, a U.S. health official said Wednesday. , "...infections around the country," Dr. Anne Schuchat,...and Respiratory Diseases at the U.S. Centers for D...
(Date:11/25/2009)...carried into the body on a carefully engineered, f...ly eliminate tumors in mammals, scientists report ...dicine . , The new approach, pioneered by bioeng...es plastic disks impregnated with tumor-specific a...the mammalian immune system to attack tumors. The ...
(Date:11/25/2009)...mimicked parts of speech colored perception of sou...ws) -- People can "hear" not only with their ears,..., In fact, sensations on the skin designed to mimi...ecipher sounds better, the Canadian scientists fou...we could use tactile information in this way," sai...
(Date:11/25/2009)...rstCall/--TheAdvisoryBoardCompany(Nasdaq: ABCO )an...perJaffrayHealthCareConferenceinNewYorkCity.Speaki...llbetheCompany,sChiefExecutiveOfficer,RobertW.Muss...elT.Kirshbaum.Thepresentationmaterialswillbeavaila...ryboardcompany.com ,throughDecember16,2009. ,, ...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...Share Repurchase Authorization -, BRAINTREE, Mass...day reported fourth quarter fiscal 2008 GAAP net,r...of $20 million, down,21%; and net earnings per sha...2%, and net earnings per share of,$1.94, up 9%., ...
...hting Key Histology Findings to Be Included ...INDIANAPOLIS, May 1 Eli Lilly and Company,will un...nual Meeting of,the American Society of Clinical O...ion), GEMZAR(R) (gemcitabine HCl for,injection), a...
...ongenital heart disease are receiving implantable ...per heart rhythm. ICDs were first introduced for a...well they work in children, who account for less t...e. It finds the devices to be life-saving, but als...
...ng a different kind of high -- approximately seven... to 12) report participating in a thrill-seeking a...lf-asphyxiation or having been choked by someone e...gical health of Ontarios youth, in the Mental Heal...
...a major step toward a practical energy source for ...izona report development of a new generation of su...ore powerful than existing motors. Their study is ...luding so-called catalytic nanomotors, are made wi...
...troke key factors in progression toward dementia ,...ression in women and stroke in men are critical fa...rench researchers report. , They analyzed data fro...start of the study. , They were assessed two and f...
Other Medicine News:Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 2Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 3Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 4Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 5Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 6Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 7Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 8Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 9Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 10Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 11Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 12Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 13Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 14Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 15Health News:Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009 16Health News:Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008 2Health News:Largest study to date finds benefits of ICDs in children 2Health News:The 'choking game,' psychological distress and bullying 2Health News:Alzheimer's Disease Risk Factors May Be Gender-Specific 2
(Date:11/24/2009)... ,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WH...r23yearsfollowinganautoaccident,wasactuallyfullyco...odMorningAmericasegment.TheDynaVoxEyeMaxwasfeature...dromeandotherconditionscanunlockcommunication. ,...ailableonlineat www.dynavoxtech.com ,, W...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--A...odaythatitwillpresentatthe21stAnnualPiperJaffrayHe...m.EST(6:00a.m.PST).TheconferenceisbeingheldatTheNe...iefExecutiveOfficerofAnadys,willprovideanoverviewo...ANA773. ,, Thecorporatepresentationwillbesimult...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics...fyNow®System,thefirstrapidandeasy-to-usediagn...tipleantiplateletagents(e.g.Plavix®andaspirin...ofAccumetrics,andGregoryJ.Tibbitts,ChiefFinancialO...viewatthe21stAnnualPiperJaffrayHealthCareConferenc...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 1Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 1China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 3
...ial Expected to Initiate in 2010 for Blinatumomab ... MITI ), a biopharmaceutical company developing no...ancer, inflammation and autoimmune diseases, today...nalysts at The Yale Club of New York City. , , ... development across Micromet,s BiTE antibody platf...
... Presented Today at 44th Annual Meeting of EASL , ... Status During Q1 Financial Results Call at 5 P.M....aceuticals, Inc. (Nasdaq: ANDS ) today announced...cleoside polymerase inhibitor, demonstrated potent...l tolerated in a Phase Ib study in which patients ...
Other Medicine Technology:Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8
Pure Eyes
Graether Collar Button
Lobob Hard Lens Soaking Solutions
Crawford Fascia Stripper
Medicine Products: